408 related articles for article (PubMed ID: 31860766)
1. Local delivery of corticosteroids in clinical ophthalmology: A review.
Fung AT; Tran T; Lim LL; Samarawickrama C; Arnold J; Gillies M; Catt C; Mitchell L; Symons A; Buttery R; Cottee L; Tumuluri K; Beaumont P
Clin Exp Ophthalmol; 2020 Apr; 48(3):366-401. PubMed ID: 31860766
[TBL] [Abstract][Full Text] [Related]
2. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.
Gaballa SA; Kompella UB; Elgarhy O; Alqahtani AM; Pierscionek B; Alany RG; Abdelkader H
Drug Deliv Transl Res; 2021 Jun; 11(3):866-893. PubMed ID: 32901367
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal steroids in the management of macular oedema.
Sivaprasad S; McCluskey P; Lightman S
Acta Ophthalmol Scand; 2006 Dec; 84(6):722-33. PubMed ID: 17083528
[TBL] [Abstract][Full Text] [Related]
4. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.
Ciulla TA; Harris A; McIntyre N; Jonescu-Cuypers C
Expert Opin Pharmacother; 2014 May; 15(7):953-9. PubMed ID: 24661081
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.
Couret C; Poinas A; Volteau C; Riche VP; Le Lez ML; Errera MH; Creuzot-Garcher C; Baillif S; Kodjikian L; Ivan C; Le Jumeau de Kergaradec LM; Chiffoleau A; Jobert A; Jaulin J; Biron L; Hervouet E; Weber M
Trials; 2020 Feb; 21(1):159. PubMed ID: 32041669
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation.
Sadiq MA; Agarwal A; Soliman MK; Hanout M; Sarwar S; Do DV; Nguyen QD
Expert Opin Drug Saf; 2015 Jul; 14(7):1147-56. PubMed ID: 25994877
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal steroids for macular edema: the past, the present, and the future.
Cunningham MA; Edelman JL; Kaushal S
Surv Ophthalmol; 2008; 53(2):139-49. PubMed ID: 18348879
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone.
Cáceres-del-Carpio J; Costa RD; Haider A; Narayanan R; Kuppermann BD
Dev Ophthalmol; 2016; 55():221-31. PubMed ID: 26502207
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
10. Sustained-release steroids for the treatment of diabetic macular edema.
Daruich A; Matet A; Behar-Cohen F
Curr Diab Rep; 2015 Nov; 15(11):99. PubMed ID: 26395924
[TBL] [Abstract][Full Text] [Related]
11. New developments in corticosteroid therapy for uveitis.
Taylor SR; Isa H; Joshi L; Lightman S
Ophthalmologica; 2010; 224 Suppl 1():46-53. PubMed ID: 20714181
[TBL] [Abstract][Full Text] [Related]
12. The use of intravitreal corticosteroids, evidence-based and otherwise.
Conti SM; Kertes PJ
Curr Opin Ophthalmol; 2006 Jun; 17(3):235-44. PubMed ID: 16794435
[TBL] [Abstract][Full Text] [Related]
13. The Role of Steroids and NSAIDs in Prevention and Treatment of Postsurgical Cystoid Macular Edema.
Grzybowski A; Kanclerz P
Curr Pharm Des; 2018; 24(41):4896-4902. PubMed ID: 30727876
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal inserts of steroids to treat diabetic macular edema.
Montero JA; Ruiz-Moreno JM
Curr Diabetes Rev; 2009 Feb; 5(1):26-32. PubMed ID: 19199895
[TBL] [Abstract][Full Text] [Related]
15. Delivery of steroids into the eye for the treatment of macular edema.
Hadayer A; Schaal S
Expert Opin Drug Deliv; 2016 Aug; 13(8):1083-91. PubMed ID: 27105838
[TBL] [Abstract][Full Text] [Related]
16. Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit.
Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
Clin Exp Ophthalmol; 2015 Apr; 43(3):234-8. PubMed ID: 25214011
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Steroids in Diabetic Macular Edema.
Lattanzio R; Cicinelli MV; Bandello F
Dev Ophthalmol; 2017; 60():78-90. PubMed ID: 28427068
[TBL] [Abstract][Full Text] [Related]
18. The role of steroids in the management of uveitic macular edema.
de Smet MD; Julian K
Eur J Ophthalmol; 2011; 21 Suppl 6():S51-5. PubMed ID: 23264329
[TBL] [Abstract][Full Text] [Related]
19. Health-economic evaluation of fluocinolone acetonide 190 µg implant in people with diabetic macular edema.
Holden SE; Currie CJ; Owens DR
Curr Med Res Opin; 2017 Oct; 33(sup2):45-52. PubMed ID: 28881146
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroids and Anti-Complement Therapy in Retinal Diseases.
Narayanan R; Kuppermann BD
Handb Exp Pharmacol; 2017; 242():309-320. PubMed ID: 27815789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
